T 1-weighted dynamic MRI with new superparamagnetic iron oxide particles (Resovist®): Results of an in vitro and in vivo study with 25 patients;T 1-gewichtete dynamische MRT mit neuen superparamagnetischen eisenoxidpartikeln (Resovist®): Ergebnisse einer studie am phantom sowie an 25 patienten

RoFo Fortschritte auf dem Gebiete der Rontgenstrahlen und der Neuen Bildgebenden Verfahren

Volumn 168, Issue 3, 1998, Pages 228-236

  Muller M ^a   Reimer, P ^a   Wiedermann, D ^a   Allkemper, T ^a   Marx, C ^a   Tombach, B ^a   Rummeny, E J ^a   Shamsi, K ^b   Balzer, T ^b   Peters, P E ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b BAYER PHARMA AG   (Germany)

Author keywords

Dynamic imaging; Focal liver lesions; MRI; Superparamagnetic iron oxide particles; T 1 effect

Indexed keywords

CONTRAST MEDIUM; IRON; OXIDE; SUPERPARAMAGNETIC IRON OXIDE; GADODIAMIDE; GADOLINIUM PENTETATE; GADOTERIDOL;

ADULT; AGED; ARTICLE; FEMALE; HEMANGIOMA; HUMAN; IMAGE QUALITY; LIVER; LIVER TUMOR; MALE; METASTASIS; METHODOLOGY; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCREAS TUMOR; PATHOLOGY; PORTAL VEIN; REPRODUCIBILITY; SPLEEN; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; LIVER CELL CARCINOMA; LIVER DISEASE; LIVER METASTASIS; LIVER PARENCHYMA; NODULAR HYPERPLASIA; PHANTOM; PRIORITY JOURNAL;

ADULT; AGED; CONTRAST MEDIA; FEMALE; HEMANGIOMA; HUMANS; IRON; LIVER; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; OXIDES; PANCREATIC NEOPLASMS; PHANTOMS, IMAGING; PORTAL SYSTEM; REPRODUCIBILITY OF RESULTS; SPLEEN;

EID: 0031596539     PISSN: 09366652     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Benderbous S, Bonnemain B. Superparamagnetic nanoparticles as blood-pool contrast agents. Radiologe 1995; 35: 248-252
2. Blouin A. Morphometry of liver sinusoidal cells. In: Wisse E, Knook DL (Hrsg.). Kupffer cells and other sinusoidal cells. Amsterdam: Elsevier/North-Holland Biomedical Press, 1977: 61-71
3. Chambon C, Clement O, Le Blanche A, Schouman-Claeys E, Frija G. Superparamagnetic iron oxides as positive MR contrast agents: In vitro and in vivo evidence. Magn Reson Imag 1993; 11: 509-519
4. Fahlvik AK, Klaveness J, Stark DD. Iron oxides as MR imaging contrast agents. J Magn Reson Imag 1993; 3: 187-194
5. Ferruci JT, Stark DD. Iron oxide-enhanced MR imaging of the liver and spleen: Review of the first 5 years. Amer J Roentgenol 1990; 155: 943-950
6. 2 relaxation times from echoplanar MR imaging in the characterization of focal hepatic lesions. Amer J Roentgenol 1993; 160: 1011-1017
7. Grandin C, Van Beers BE, Robert A, Gigot JF, Geubel A, Pringot J. Benign hepatocellular tumors: MRI after Superparamagnetic iron oxide administration. J Comput Assist Tomogr 1995; 19: 412-418
8. 1-weighted MR SE images by Superparamagnetic iron oxide particles. J Comput Assist Tomogr 1994; 18: 888-896
9. Hamm B, Staks T, Taupitz M, Maibauer R, Speidel A, Huppertz A, Frenzel T, Lawaczeck R, Wolf KJ, Lange L Contrast-enhanced MR imaging of liver and spleen: First experience in humans with a new Superparamagnetic iron oxide. J Magn Reson Imag 1994; 4: 659-668
10. Hamm B, Thoeni RF, Gould RG, Bernadino ME, Lüning M, Saini S, Mahfouz AE, Taupitz M, Wolf KJ. Focal liver lesions: characterization with nonenhanced and dynamic contrast material-enhanced MR imaging. Radiology 1994; 190: 417-423
11. Hendrick RE, Haacke EM. Basic physics of MR contrast agents and maximization of image contrast. J Magn Reson Imag 1993; 3: 137-148
12. Josephson L, Lewis J, Jacobs P, Hahn PF, Stark DD. The effects of iron oxides on proton relaxivity. Magn Reson Imag 1988; 6: 647-653
13. Laniado M, Chachuat A. Verträglichkeitsprofil von Endorem®. Radiologe 1995; 35: 266-270
14. Mayo-Smith WW, Saini S, Slater G, Kaufman JA, Sharma P, Hahn PF. MR contrast material for vascular enhancement: Value of superparamagnetic iron oxide. Amer J Roentgenol 1996; 166: 73-77
15. Mergo PJ, Helmberger T, Nicolas AI, Ros PR. Ring enhancement in ultrasmall iron oxide MR imaging: A potential new sign for characterization of liver lesions. Amer J Roentgenol 1996; 166: 379-384
16. Reimer P, Rummeny EJ, Daldrup HE, Balzer T, Tombach B, Berns T, Peters PE. Clinical results with Resovist: A phase 2 clinical trial. Radiology 1995; 195: 489-496
17. Schering AG, Berlin. SHU 555 A, Investigator's Brochure. 1995: 13-18
18. Saini S, Edelman RR, Sharma P, Li W, Mayo-Smith W, Slater GJ, Eisenberg PJ, Hahn PF. Blood-pool MR contrast material for detection and characterization of focal hepatic lesions: Initial clinical experience with ultrasmall superparamagnetic iron oxide (AMI-227). Amer J Roentgenol 1995; 164: 1147-1152
19. Steudel A, Harder T, Träber F, Dewes W, Schlolaut K-H, Köster O. Relaxationszeitmessung in der kernspintomographischen Differentialdiagnose von Lebertumoren. Fortschr Röntgenstr 1989; 151: 449-455
20. 1-Effekt für die MR-Diagnostik fokaler Leberläsionen? Fortschr Röntgenstr 1996; 165: 364-370
21. Vogl TJ, Hammerstingl R, Pegios W, Hamm B, Eibl-Eibesfeldt A, Woessmer B, Lissner J, Felix R. Wertigkeit des leberspezifischen superparamagnetischen Kontrastmittels AMI-25 für die Detektion und Differentialdiagnose lebereigener Tumoren versus Metastasen. Fortschr Röntgenstr 1994; 160: 319-328
22. Vogl TJ, Hammerstingl R, Schwarz W, Kümmel S, Müller PK, Balzer T, Lauten MJ, Balzer JO, Mack MG, Schimpfky C, Schrem H, Bechstein WO, Neuhaus P, Felix R. Magnetic resonance imaging of focal liver lesions: Comparison of the superparamagnetic iron oxide Resovist versus gadolinium-DTPA in the same patient. Invest Radiol 1996; 31: 696-708
23. Wisse E, Doucet D, Van Bossuyt H. A transmission electron microscopic study on the uptake of AMI-25 by sinusoidal liver cells. In: Wisse E, Knook DL (Hrsg.). Cells of the hepatic sinusoid, Vol. 3. Leiden: Kupffer Cell Foundation, 1991: 534-539
24. Yamamoto H, Yamashita Y, Yoshimatsu S, Baba Y, Takahashi M. MR enhancement of hepatoma by superparamagnetic iron oxide (SPIO) particles. J Comput Assist Tomogr 1995; 19: 665-667